Inactive Instrument

Calendar Hemispherx BioPharma, Inc Nyse

Equities

US42366C1036

End-of-day quote Nyse Other stock markets
- ^USD	-

Apr. 10	AIM Immunotech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer	CI
Apr. 02	Transcript : AIM ImmunoTech Inc., Q4 2023 Earnings Call, Apr 02, 2024

Chart calendar Hemispherx BioPharma, Inc

35647fc3174ea714cd8a50d.dtjkk1yhpV3QZQLyxjZyjcVoG-peggkPPQ_Gl22bI70.Gp2B2GrX8jy9HEaQvnMl7qEjadsB7z5HVHepoC6pRe4T7JWkLdfBa-EkMg~2ad6115ab448ea4612ed4a65753d2579

Upcoming events on Hemispherx BioPharma, Inc

2024-05-15	Q1 2024 Earnings Release (Projected)
2024-08-12	Q2 2024 Earnings Release (Projected)
2024-11-14	Q3 2024 Earnings Release (Projected)
2025-04-06	Q4 2024 Earnings Release (Projected)

Past events on Hemispherx BioPharma, Inc

2024-04-03 01:35 pm	MedInvest Biotech & Pharma Investor Conference
2024-04-02 08:30 am	Q4 2023 Earnings Call
2024-04-02 07:30 am	Q4 2023 Earnings Release
2024-03-20 12:00 pm	AIM ImmunoTech Virtual Investor Lunch Break Conference
2024-01-04	Annual General Meeting - Proxy Fight for Board Control
2023-12-05 12:00 am	Noble Capital Markets Emerging Growth Equity Conference
2023-12-01 11:00 am	Annual General Meeting - Proxy Fight for Board Control
2023-11-15 08:30 am	Q3 2023 Earnings Call
2023-11-15 07:30 am	Q3 2023 Earnings Release
2023-09-21	Marie Sklodowska-Curie on Cancer Research and Care Symposium
2023-09-11 07:00 am	H.C. Wainwright Global Investment Conference
2023-08-15 08:30 am	Q2 2023 Earnings Call
2023-08-15 06:45 am	Q2 2023 Earnings Release
2023-07-12 11:00 am	Virtual Investor Summer Spotlight Conference
2023-06-21 12:00 pm	Maxim Group Virtual Healthcare Conference
2023-05-16 08:30 am	Q1 2023 Earnings Call
2023-05-15 08:45 am	Q1 2023 Earnings Release
2023-04-03 08:30 am	Q4 2022 Earnings Call
2023-04-03 06:30 am	Q4 2022 Earnings Release
2023-01-18 11:00 am	Virtual Investor Conference

Annual results

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million USD	Released Forecast Spread	0,14 0,48 -71.09%	0,16 0,19 -14.66%	0,14 0,12 11.88%	0,14 0,24 -41.17%	0,20 0,16 28.66%	0,00
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00
EBIT Million USD	Released Forecast Spread	-12,4 -11,9 -4.73%	-15,0 -13,0 -15.83%	-17,1 -15,9 -7.09%	-19,9 -20,0 0.21%	-31,9 -24,3 -31.42%	-27,0
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-9,53 -11,0 13.11%	-14,4 -13,6 -5.53%	-19,1 -17,5 -9.2%	-19,4 -20,9 7.06%	-29,0 -21,6 -34.38%	-27,0
Net income Million USD	Released Forecast Spread	-9,53 -11,0 13.11%	-14,4 -13,4 -7.52%	-19,1 -17,9 -7%	-19,4 -20,3 4.28%	-29,0 -22,5 -28.57%	-27,0
EPS USD	Released Forecast Spread	-2,62 -3,73 29.66%	-0,45 -0,43 -5.47%	-0,40 -0,38 -6.19%	-0,40 -0,44 8.05%	-0,60 -0,45 -33.33%	-0,54
Announcement Date		30/03/20	31/03/21	31/03/22	31/03/23	01/04/24	-

Quarterly results

Fiscal Period	December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4
Net sales Million USD	Released Forecast Spread	0,05 0,04 36.35%	0,03 0,10 -67%	0,03 0,14 -78.21%	0,02 0,02 40%	0,06 0,18 -69.51%	0,05 0,00 -	0,04 0,02 82.61%	0,05 0,02 91.67%	0,07 0,04 78.08%
EBIT Million USD	Released Forecast Spread	-5,67 -4,54 -24.85%	-3,15 -4,50 29.96%	-4,70 -3,60 -30.26%	-6,52 -4,55 -43.21%	-5,56 -5,62 1.12%	-4,30 -5,50 21.91%	-5,46 -5,13 -6.42%	-8,16 -5,58 -46.26%	-14,0 -6,37 -119.79%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-5,85 -4,24 -38.04%	-3,82 -4,50 15.11%	-4,85 -3,62 -33.95%	-6,39 -4,92 -29.78%	-4,39 -5,89 25.52%	-3,66 -5,50 33.44%	-4,91 -5,34 8.06%	-7,82 -5,76 -35.74%	-12,6 -5,53 -127.5%
Net income Million USD	Released Forecast Spread	-5,85 -4,54 -28.74%	-3,82 -4,50 15.11%	-4,85 -3,62 -33.95%	-6,39 -4,92 -29.78%	-4,39 -5,89 25.52%	-3,66 -5,50 33.44%	-4,91 -5,34 8.06%	-7,82 -5,76 -35.74%	-12,6 -5,53 -127.5%
EPS USD	Released Forecast Spread	-0,12 -0,09 -28.58%	-0,08 -0,09 11.11%	-0,10 -0,08 -33.33%	-0,13 -0,10 -30%	-0,09 -0,13 28%	-0,08 -0,11 27.27%	-0,10 -0,11 9.09%	-0,16 -0,12 -39.13%	-0,26 -0,09 -188.89%
Announcement Date		31/03/22	13/05/22	15/08/22	14/11/22	31/03/23	15/05/23	14/08/23	14/11/23	01/04/24

Upcoming sector events for Hemispherx BioPharma, Inc

2024-04-23 07:30 am	KINIKSA PHARMACEUTICALS, LTD.: Q1 2024 Earnings Release
2024-04-23	INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23	SINOCELLTECH GROUP LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23	SHANGHAI MEDICILON INC.: Q4 2023 Earnings Release
2024-04-24 04:05 pm	VIKING THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24	JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24	BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24	PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24	REMEGEN CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24	HITGEN INC.: Q4 2023 Earnings Release

More events

Past sector events for Hemispherx BioPharma, Inc

2024-04-17	BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-17	JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release
2024-04-12	SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release
2024-04-10 07:00 am	NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-08	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release
2024-04-02 03:06 am	TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release
2024-03-31	PEPTRON, INC.: Q4 2023 Earnings Release (Projected)
2024-03-31	BIONEER CORPORATION: Q4 2023 Earnings Release (Projected)
2024-03-29 08:30 am	INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release
2024-03-28	BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release